Valuation: Yuhan Corporation

Capitalization 7,904B 5.82B 5.02B 4.72B 4.28B 7.9B 500B 8.91B 55.07B 21.46B 229B 21.85B 21.38B 839B P/E ratio 2025 *
68.6x
P/E ratio 2026 * 46.1x
Enterprise value 7.85B 5.78M 4.99M 4.69M 4.25M 7.84M 497M 8.85M 54.71M 21.32M 228M 21.7M 21.25M 834M EV / Sales 2025 *
3.44x
EV / Sales 2026 * 3.14x
Free-Float
67.64%
Yield 2025 *
0.46%
Yield 2026 * 0.46%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.19%
1 week+2.41%
Current month+1.92%
1 month-0.65%
3 months-14.82%
6 months-11.27%
Current year-11.05%
More quotes
1 week 105,500
Extreme 105500
108,800
1 month 102,300
Extreme 102300
110,900
Current year 100,400
Extreme 100400
140,700
1 year 74,000
Extreme 74000
166,900
3 years 47,571.43
Extreme 47571.4286
166,900
5 years 41,464.2
Extreme 41464.2047
166,900
10 years 24,550.49
Extreme 24550.4865
166,900
More quotes
Manager TitleAgeSince
Chief Executive Officer 70 2021-03-18
Director of Finance/CFO 57 -
President 66 2024-03-14
Director TitleAgeSince
Chairman 73 2021-03-18
Director/Board Member 70 2015-03-19
Director/Board Member 60 2020-02-29
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.19%+2.41%+42.68%+116.23% 5.8B
-0.13%-0.48%-33.34%-30.09% 57.7B
-0.52%+1.02%-8.59%-11.54% 9.05B
-0.11%-0.61%+8.93%+20.82% 6.65B
+1.77%+1.66%+17.37%+29.25% 5.18B
-2.49%-1.20%+63.23%+14.01% 3.71B
-0.28%+0.47%-1.19%+20.13% 2.02B
+1.37%-2.05%+24.93%+18.37% 1.79B
+1.64%-3.74%-60.50%-4.52% 1.75B
+1.46%+2.46%-21.09%-26.50% 1.74B
Average +0.26%-0.98%+3.24%+14.62% 9.54B
Weighted average by Cap. -0.07%-0.81%-15.41%-8.43%
See all sector performances

Financials

2025 *2026 *
Net sales 2,280B 1.68B 1.45B 1.36B 1.24B 2.28B 144B 2.57B 15.89B 6.19B 66.13B 6.3B 6.17B 242B 2,462B 1.81B 1.56B 1.47B 1.33B 2.46B 156B 2.78B 17.15B 6.68B 71.39B 6.8B 6.66B 261B
Net income 117B 86.48M 74.62M 70.14M 63.6M 117M 7.43B 132M 818M 319M 3.4B 324M 318M 12.46B 175B 129M 111M 105M 94.82M 175M 11.08B 197M 1.22B 475M 5.08B 484M 474M 18.58B
Net Debt -51.05B -37.61M -32.45M -30.5M -27.66M -51M -3.23B -57.55M -356M -139M -1.48B -141M -138M -5.42B -174B -128M -110M -104M -94.09M -173M -10.99B -196M -1.21B -472M -5.04B -480M -470M -18.43B
More financial data * Estimated data
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical segment is engaged in the production and sale of non-prescription drugs including anti-inflammatory drugs, as well as prescription drugs such as drugs for hepatitis, diabetes, and hypertension. The Life and Health segment is involved in the production and sale of household goods and animal healthcare (AHC) products, including bleach, antibacterial agents. The Overseas Business segment supplies raw drugs to domestic and overseas markets. The Company also sells licenses. The Company distributes its products in domestic and overseas markets such as Europe, Asia and United States.
Employees
2,038
Calendar
More about the company
Date Price Change Volume
25-06-16 106,300.00 -0.19% 269,720
25-06-13 106,500.00 -1.75% 467,882
25-06-12 108,400.00 +1.12% 374,512
25-06-11 107,200.00 -0.09% 235,227
25-06-10 107,300.00 0.00% 363,005

End-of-day quote Korea S.E., June 15, 2025

More quotes
Trading Rating
Investor Rating
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
106,300.00KRW
Average target price
144,266.67KRW
Spread / Average Target
+35.72%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A000100 Stock